Bioactivity | (-)-Pinoresinol 4-O-glucoside ((-)-Pinoresinol 4-O-β-D-glucopyranoside) is a potent and orally active α-glucosidase inhibitor with an IC50 value of 48.13 µM. (-)-Pinoresinol 4-O-glucoside increases cell migration and early differentiation of pre-osteoblasts. (-)-Pinoresinol 4-O-glucoside increases protein level of BMP2, p-Smad1/5/8, RUNX2. (-)-Pinoresinol 4-O-glucoside attenuates oxidative stress, hyperglycemia and hepatic toxicity. (-)-Pinoresinol 4-O-glucoside has the potential for the research of osteoporosis and periodontal disease[1][2]. |
Target | IC50: 48.13 µM (α-Glucosidase) |
Invitro | (-)-Pinoresinol 4-O-glucoside (0、10、30 µM;24 小时) 在含有 50 μg/mL 的成骨补充培养基 (OS) 中增加前成骨细胞分化过程中的细胞迁移[1].(-)-Pinoresinol 4-O-glucoside (10、30 µM;7 天) 在前成骨细胞分化过程中增加早期分化并增加矿化结节的形成[1]。(-)-Pinoresinol 4-O-glucoside (10、30 µM;3 天) 增加前成骨细胞中 BMP2、ALP、OCN mRNA 水平的表达[1]。(-)-Pinoresinol 4-O-glucoside (10、30 µM;3 天) 增加 BMP2、p-Smad1/5/8、RUNX2 的蛋白表达水平[1]。 RT-PCR[1] Cell Line: |
In Vivo | (-)-Pinoresinol 4-O-glucoside (50 mg/kg;口服;20 天) 减轻小鼠的氧化应激、高血糖和肝毒性[2]。 Animal Model: |
Name | (-)-Pinoresinol 4-O-glucoside |
CAS | 41607-20-9 |
Formula | C26H32O11 |
Molar Mass | 520.53 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Park KR, et al. Effects of PIN on Osteoblast Differentiation and Matrix Mineralization through Runt-Related Transcription Factor. Int J Mol Sci. 2020 Dec 16;21(24):9579. [2]. Youssef FS, et al. Pinoresinol-4-O-β-D-glucopyranoside: a lignan from prunes (Prunus domestica) attenuates oxidative stress, hyperglycaemia and hepatic toxicity in vitro and in vivo. J Pharm Pharmacol. 2020 Dec;72(12):1830-1839. |